Aims/hypothesis The pathogenesis of diabetes and the success of islet transplantation depend on the control of pancreatic beta cell fate.
notch homologue 1 (NOTCH1) protein level was decreased upon serum withdrawal, as well as after treatment with a phosphatidylinositol 3-kinase inhibitor, or hydroxy-2-naphthalenylmethylphosphonic acid, an insulin receptor inhibitor. While islets cultured in DAPT did not exhibit defects in insulin secretion, indicating that differentiation is unaltered, inhibiting gamma-secretase-dependent Notch activation led to a dose-dependent increase in caspase-3-dependent apoptosis in both MIN6 cells and human islets. Conversely, gamma-secretase overactivity resulted in an accumulation of cleaved NOTCH1 and protection from apoptosis. Conclusions/interpretation Together these results show that the Notch/Ngn3 signalling network is intact and functional in adult islets. This pathway represents an attractive target for modulating beta cell fate in diabetes, islet transplantation and efforts to derive beta cell surrogates in vitro.
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Introduction
Notch signalling plays a critical role in many developmental processes, influencing differentiation, proliferation and apoptosis [1, 2] . The Notch pathway includes a conserved family of transmembrane receptors (NOTCH1-4) that interact with a number of specific ligands (the delta-like family; jagged 1 and 2) to regulate cell fate [1, 3] . Interaction between Notch receptors and these ligands leads to intracellular cleavage of Notch receptors by the gamma-secretase complex [4] . The cleaved Notch intracellular domain traffics to the nucleus where it interacts with transcription factors. This activates the expression of hairy and enhancer of split (e.g. Hes1) transcriptional repressors, which in turn repress expression of downstream target genes such as neurogenin 3 (Ngn3, also known as Neurog3) [3] . Several studies have illustrated the importance of the Notch pathway in the control of cell fate during development of both pancreatic endocrine and exocrine tissue [5] [6] [7] [8] . It is well documented that the transient expression of the Notch target gene Ngn3 defines the endocrine precursor pool in prenatal development [5, 8, 9] . To the best of our knowledge detailed studies on the expression and regulation of Ngn3 in the adult pancreas have not been reported. While there is strong evidence that Notch regulates beta cell mass during prenatal development by controlling the number of Ngn3-positive endocrine precursor cells, little is known about the activity of this network in adult islets.
Although primarily involved in pancreatic embryogenesis, it is possible that the Notch pathway may retain a small but significant level of activity in the adult and may play a role in islet cell turnover, maintenance or gene expression. Indeed, Notch has been shown to regulate apoptosis in a number of mature cell types, including thymocytes, as well as some cancers [10] [11] [12] . Furthermore, Notch pathway components are re-expressed in exocrine cells after experimentally induced pancreas injury [13, 14] . Interestingly, a recent study demonstrated the ability of the cytokine IL-1β to rapidly increase the mRNA expression and protein levels of members of the Notch pathway in rat beta cells [15] . The aim of the present study was to determine whether the Notch pathway remains functional in adult islets. Our results show that Notch receptors, their ligands and their target genes are expressed in adult islets. We also find that inhibition of growth factor signalling reduced Notch activation in mouse and human islets. In addition, blocking the Notch pathway activity induced apoptosis in primary beta cells. We present evidence that this key 'developmental' pathway remains intact in adult islets. Our results suggest that the Notch pathway represents an attractive target in efforts to increase beta cell survival in diabetes or islet transplantation.
Methods
Reagents The gamma-secretase inhibitor, N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT), was purchased from Sigma (St Louis, MO, USA); LY294002 and hydroxy-2-naphthalenylmethylphosphonic acid (HNMPA) were obtained from Calbiochem (La Jolla, CA, USA). All other reagents were from Sigma.
Cell culture Primary islets were isolated from 3-to 6-monthold C57Bl6/J mice (Jax, Bar Harbor, MA, USA) using collagenase and filtration as described previously [16] . Human islets were provided with consent through the auspices of the Michael Smith Foundation for Health Research Centre (MSFHR) for Human Islet Transplant and Beta Cell Regeneration (Vancouver, BC, Canada), directed by G. Warnock. Our preparations of human islets were from donors aged 49-65 years (from both sexes), and cold ischaemia time was never more than 12 h. The human islet preparations typically stained >75% positive for beta cells using dithizone. After islet dispersion and culture >50% of the round 'endocrine' cells stained robustly for insulin (data not shown). Human and mouse islets were cultured in 35×10 mm Nunc suspension dishes (Nalge, Rochester, NY, USA) at 37°C and 5% CO 2 in RPMI 1640 medium with glucose adjusted as indicated in each experiment. The medium was supplemented with 100 IU/ml penicillin-100 μg/ml streptomycin (10%, v/v) FCS and brought to pH 7.4 with NaOH [17, 18] . For experiments designed to test the effects of exogenous insulin, larger volumes of medium were used to reduce insulin build-up as in our previous studies [19] . The mouse-derived MIN6 cells were maintained and cultured as described [20] in DMEM medium containing 25 mmol/l glucose or 5 mmol/l glucose (as indicated), 10% FCS and 100 IU/ml penicillin-100 μg/ml streptomycin (Invitrogen, Burlington, ON, Canada).
Gene expression analysis Total RNA was isolated from mouse primary islets or cells using the Qiagen RNeasy kit (Mississauga, ON, Canada). cDNA was reversed transcribed using Superscript III (Invitrogen). Primer sequences used for Notch1, -2, -3 and -4, Jag1 and -2, delta-like 1, 2, 3 and 4 (Dll1, -2, -3 and -4) and Hes1 have been described [21] . Primers for Ngn3 were: forward TGC AGC CAC ATC AAA CTC TC; reverse GGT CAC CCT GGA AAA AGT GA, and the expected product size was 139 bp. Primers for β-actin were: forward GGA AAT CGT GCG TGA CAT CAA AG; reverse ATC TGC TGG AAG GTG GAC AGT GAG, and the expected product size was 430 bp.
Analysis of programmed cell death Islet apoptosis was measured using a previously described variation of a PCR-enhanced DNA-laddering protocol modified for use in small numbers of islets [17] . In order to compare data from separate gels, band intensity was normalised to the average of the control cultures. Cell death was also detected using propidium iodide (Sigma-Aldrich, Oakville, ON, Canada; 500 ng/ml) and Hoechst 33258 (Invitrogen; 500 ng/ml) after 30 min incubation with the dyes. Cells were visualised using an Axiovert 200M microscope (Zeiss, Thornwood, NY, USA) and imaged using a Coolsnap HQII camera (Photometric, Tucson, AZ, USA). Semi-automated counting of propidium iodide-and Hoechst-positive cells was performed using SlideBook software (Intelligent Imaging Innovations, Boulder, CO, USA).
Insulin secretion analysis by islet perifusion After overnight culture with or without 10 μmol/l DAPT, groups of 100 size-matched islets were suspended with Cytodex microcarrier beads (Sigma-Aldrich) in the 300 μl plastic chambers of an Acusyst-S perifusion apparatus (Endotronics, Minneapolis, MN, USA). Under temperature-and CO 2 -controlled conditions, the islets were perifused at 0.5 ml/min with a Krebs-Ringer buffer containing (in millimole per litre) 129 NaCl, 5 NaHCO 3 , 4. Immunoblot analysis Western blots were performed according to standard methods. Briefly, human and mouse islets (cultured in groups of 140 in 15 ml of medium) were washed twice with 1× PBS before adding cell lysis buffer with protease inhibitor (Cell Signaling, Beverly, MA, USA). Whole cell lysates were sonicated and protein concentrations were determined by using the BCA protein assay (Pierce Biotechnology, Rockford, IL, USA). Protein lysates (15-30 μg) were subjected to PAGE electrophoresis, transferred to polyvinylidene fluoride membranes, which were then blocked with I-block solution (Tropix, Bedford, MA, USA), washed and probed with primary antibodies, including rabbit monoclonal anti-Notch1, rabbit monoclonal anti-cleaved caspase-3, rabbit polyclonal anti-B-cell leukaemia/lymphoma 2 (BCL2), mouse monoclonal anti-transformation related protein 53 (p53) and rabbit polyclonal anti-presenilin-1 (PSEN1; Cell Signaling). Mouse monoclonal antibody to β-actin was from Novus Biologicals (Littleton, CO, USA). Immunodetection was performed with ECL Western Blotting Detection Reagents from Amersham (Buckinghamshire, UK). Densitometric analysis employed either Image J (NIH, Bethesda, MD, USA) or Adobe Photoshop.
Immunofluorescence staining Immunofluorescence analysis of dispersed islet cells was performed essentially as described [17, 22] using a Zeiss 200M microscope. Images were analysed and quantified using SlideBook software (Intelligent Imaging Innovations). Deconvolution was used to remove out-of-focus light in high-resolution images (×100 objective; 1.45 numerical aperture). Neurogenin 3 (NGN3) rabbit antiserum was kindly provided by M. German (University of California at San Francisco) or purchased from Cemines (Golden, CO, USA). Mouse monoclonal anti-glucacon antibody was from Sigma. Guinea pig anti-insulin antibody was from Linco Research. DAPI was used as a nuclear counterstain. Primary antibodies were omitted as negative controls in each case.
Transfection and infection of MIN6 cells A full-length
Psen1 clone in a CMV promoter vector (pCMV6-XL5-PSEN1) was purchased from Origene (Rockville, MD, USA). MIN6 cells were transfected with 1 μg of either pCDNA3 (as control) or pCMV6-XL5-PSEN1 using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. Cells were incubated for 48 h at 37°C with 5% CO 2 and subsequently harvested for western blot analysis as described above. Adenovirus expressing Ngn3 under CMV promoter was kindly provided by M. German (University of California at San Francisco). Adenovirus expressing beta-galactosidase (βGal) under CMV promoter was a gift from T. Kieffer (University of British Columbia). For western blot analysis, MIN6 cells were infected with either five multiplicities of infection (MOI) of adeno-βGal (control) or 1, 5 or 10 MOI of adeno-Ngn3 for 48 h.
Statistics Results are presented as means ± SEM. Data were analysed by Student's t test. Results were considered to be statistically significant when p values were <0.05.
Results
Notch pathway components are expressed in adult mouse islets We examined whether key elements of the Notch signalling pathway are expressed in both MIN6 cells and primary mouse islets using RT-PCR. Our results demonstrated that many components of the Notch signalling pathway and Ngn3, an essential Notch target gene, were expressed in adult mouse islets (Fig. 1 ). All four Notch receptors (Notch1, -2, -3, -4) were expressed, with Notch1 the prominent receptor isoform in adult mouse islets and MIN6 cells. All four ligands tested were expressed at different levels. Dll1 was the most detectable Notch ligand in mouse islets and MIN6 cells. Hes1, a major target of Notch in prenatal development, was present at low abundance in MIN6 cells but was not detected in primary mouse islets.
Next, we further examined the expression of Ngn3, a major downstream effector of Notch signalling that is essential for development of the endocrine pancreas [5] [6] [7] . Ngn3 mRNA was detected in adult mouse islets and MIN6 cells (Fig. 1) . We also detected a modest amount of NGN3 protein in adult human islets, mouse islets, and in MIN6 cells using western blot analysis (Fig. 2a) . We detected NGN3 protein using immunofluorescence labelling in dispersed adult mouse beta cells (Fig. 2b ) and alpha cells (not shown), dispersed human islet cells (not shown) and in pancreatic sections from adult mice (Fig. 2c ), but not in negative controls (not shown). NGN3 was produced in ∼60% of glucagon-expressing alpha cells. NGN3 was found in ∼20% of beta cells. NGN3 immunoreactivity was detected in both the cytoplasm and the nucleus of beta cells. High-resolution imaging and deconvolution (to remove out-of-focus light) revealed a punctate NGN3 staining pattern. The most intense NGN3 staining was observed in a few cytoplasmic structures, whereas less intense, but more abundant puncta were found in the nucleus (Fig. 2d) . To verify the specificity of our NGN3
Notch1
Notch2 Notch3 Dll1 β-Actin c Pancreatic sections from adult mouse were stained as above (scale bar 100 μm). d High-resolution deconvolution imaging of NGN3 (green) and nuclei (blue) in MIN6 cells was obtained with a ×100 objective (scale bar 5 μm). e, f Immunofluorescent localisation of NGN3 (red) in MIN6 cells infected with five MOI of an adenovirus vector overexpressing βGal or Ngn3 as indicated. DAPI was included to identify nuclei (blue). Scale bar=20 μm. Images shown are representative of at least three preparations antibody staining, we overexpressed Ngn3 in MIN6 cells using an adenovirus. A dramatic increase in NGN3 staining was observed compared with cells infected with a βGal adenovirus (Fig. 2e) . The intensity of NGN3 staining in the nuclei was 68±5% relative to the staining in the cytoplasm (Fig. 2f) . Together, the observation that Notch, its ligands and its target genes are expressed in adult islets suggests that the Notch pathway may retain some activity in normal tissues after prenatal pancreatic development is complete.
Extracellular growth factor signalling affects the Notch pathway As an initial step towards determining whether extracellular growth cues can modulate the Notch/neurogenin pathway in adult islets, we compared islets cultured with and without serum. In these experiments, removal of serum resulted in a significant (32%) decrease in cleaved NOTCH1 protein in mouse islets (Fig. 3a,b) . Removal of serum also decreased cleaved NOTCH1 in human islets, and accordingly, increased NGN3 protein (Fig. 3c ). This suggested that extracellular signals influence Notch activation in adult pancreatic islets.
To investigate whether classic growth factor signalling pathways are involved in the regulation of Notch1 and Ngn3 in adult islets, we incubated mouse and human islets in medium containing inhibitors of signalling components common to insulin, IGF and other growth factors. We found that inhibition of phosphatidylinositol 3-kinase with LY-294002 reduced the cleaved NOTCH1 protein level in both primary mouse and human islets (Fig. 3d-g ). In mouse islets this was associated with increased Ngn3 mRNA (data not shown). HNMPA, an inhibitor of the insulin receptor tyrosine kinase, also significantly reduced activated NOTCH1 protein in primary mouse islets (Fig. 3d,e) . As a positive control, the gamma-secretase inhibitor DAPT also lowered NOTCH1 protein levels in mouse islets (Fig. 3d,e) . Activation of Notch1 would be expected to negatively regulate Ngn3. Accordingly we observed an increase in Ngn3 mRNA expression and protein levels after blocking the gamma-secretase (see below). These results indicate that the Notch pathway can be modulated in adult primary islets by growth factor signalling, although they do not inform as to which specific growth factors are involved. We tested three candidate growth factors [insulin, IGF-I and fibroblast growth factor 10 (FGF10)] under the serum-free conditions with which we have previously observed robust effects of insulin [19] , but were unable to discern significant differences in cleaved NOTCH1 at 48 h (data not shown). These results suggest that Notch may be regulated by a serum component other than insulin, IGF-I or FGF10, or that the effects of these hormones occur on a different time-scale from that tested. Several studies have implicated Notch and NGN3 in the control of differentiation during fetal development that ultimately leads to mature beta cell function [4] [5] [6] [7] 9] . We have shown that the active Notch fragment is reduced by the gamma-secretase inhibitor DAPT in beta cells. We next asked whether mature beta cell function requires intact Notch signalling. Glucose-stimulated insulin release is the primary function of differentiated beta cells. We found that blocking the Notch pathway with DAPT did not significantly inhibit glucose-or KCl-stimulated insulin release in primary mouse islets (Fig. 4) . This suggests that the Notch pathway does not play a role in glucose signalling or insulin exocytosis in mature beta cells.
The Notch pathway regulates beta cell apoptosis A number of reports have indicated the Notch pathway can suppress apoptotic cell death, depending on the cell context [1, 10, 23] . To determine whether Notch plays a role in the survival of mature beta cells, we examined the effect of Notch pathway inhibition on primary human and mouse islets and MIN6 cells. We took advantage of the gammasecretase inhibitor DAPT, which reduces active Notch protein in many cell types [24] [25] [26] [27] , including primary islet cells (see above). Mouse islets and MIN6 cells treated with DAPT for 24 h showed a significant increase in apoptosis, measured with PCR-enhanced DNA ladders (Fig. 5a-c) . MIN6 cells also exhibited a dose-dependent increase in cell death as evidenced by propidium iodide incorporation (Fig. 5d,e) . This was accompanied by a dose-dependent increase in caspase 3 activation measured by western blot after 24 h (Fig. 6a) , as well as 6 h and 12 h (data not shown). An increase in the number of cleaved caspase 3-positive MIN6 cells was confirmed in cultures treated with DAPT using immunofluorescence microscopy (Fig. 6c) . DAPT also induced a dose-dependent increase in caspase 3 activation in human islets (Fig. 6b) . Interestingly, DAPT did not induce apoptosis in MIN6 cells or human islets cultured in high glucose. In fact, DAPT was actually protective at some doses (Fig. 6a,b ). We also examined other possible targets of the gamma-secretase, as well as proteins known to play a role in beta cell death. Levels of p53 were unchanged (Fig. 6d) . No significant changes in the levels of BCL2 or BCL2-associated X protein (BAX) were identified (data not shown). Together, these results indicate that inhibiting Notch activation by ∼60% with DAPT (Fig. 3d,e) induces caspase 3-dependent beta cell apoptosis and therefore suggest that the Notch pathway is a regulator of programmed cell death in mature islet cells.
Next, we tested whether Ngn3, a well-characterised target of Notch in the embryonic pancreas, may also affect apoptosis in mature beta cells. First we confirmed that Ngn3 could be increased under conditions of inhibited NOTCH1. Indeed, treating mouse islets with DAPT resulted in a dose-dependent increase in Ngn3 mRNA (Fig. 7a) . Similarly, NGN3 protein was increased in MIN6 cells treated with the gamma-secretase inhibitor (Fig. 7b,c) . Based on our results up to this point, and the fact that NOTCH1 is a negative regulator of Ngn3, one would expect that NGN3 may be pro-apoptotic in adult beta cells. We tested this hypothesis using adenovirus-mediated overexpression of Ngn3. Overexpressing Ngn3, either approximately fourfold or 16-fold (Fig. 7d,e) , resulted in a significant increase in apoptosis, as indicated by caspase 3 cleavage (Fig. 7d,f) . These results are consistent with the idea that a signalling network involving the gamma-secretase, Notch and NGN3 is present and active in mature beta cells.
Finally, to complement our experiments with DAPT, we examined the effect of gamma-secretase overactivity. PSEN1, an essential component of the gamma-secretase, was overproduced approximately threefold in MIN6 cells (Fig. 8a,b,d,e) . This resulted in a significant increase in cleaved/activated NOTCH1 (Fig. 8a,c) and a decrease in programmed cell death, as indicated by a decrease in caspase 3 cleavage (Fig. 8d,f) and propidium iodide incorporation (Fig. 8g ). These results demonstrate that increasing NOTCH1 activation is associated with a protective effect in beta cells. 
Discussion
The present study was undertaken to determine whether the Notch pathway remains functional in adult islets. Our study produced four major findings. First, we have demonstrated that Notch pathway components and target genes are expressed in adult islets. Second, inhibition of growth factor signalling inhibits Notch activation in mouse and human islets. Third, blocking the Notch cleavage/activation at the level of the gamma-secretase induced apoptosis in adult islet cells, whereas increasing Notch activation was associated with an anti-apoptotic effect. Fourth, the Notch target gene Ngn3 is present in adult beta cells where it appears to play a pro-apoptotic role at very high levels. Together these findings illustrate the potential of manipulating Notch to control cell fate in adult islet cells.
Several studies have implicated Notch in the regulation of exocrine and endocrine cell fate during pancreatic development [5] [6] [7] . It was reported that Notch1 and Notch2 expression starts to decline in embryonic mouse pancreas after embryonic day 14.5 [28, 29] . Others have reported little or no expression of Notch pathway components in human adult pancreatic ductal epithelium [27] , or in whole adult rat pancreas [14] . Notch was found in differentiated neurons of the adult retina and it was speculated that Notch might confer some degree of plasticity on post-mitotic neurons [30] . In the present study, we demonstrate the presence of Notch pathway components in adult pancreatic cells, using a combination of MIN6 cells, mouse islets and human islets. Each of these models has specific limitations and advantages. For example, human islets often contain substantial numbers of non-beta cells, whereas MIN6 cells may not be fully differentiated. Notwithstanding, the combination of all three models helps support a role for Notch in mature islet cells, including beta cells. Although the role of the Notch signalling pathway in the pancreas after birth remains poorly understood, these observations suggest that this 'developmental' network may be reactivated in adult beta cells, perhaps to control proliferation, differentiation or survival.
One potentially controversial finding of the present study was the detection of NGN3 and its modulation by Notch in adult islets. Ngn3 is required for the development of all endocrine cell lineages of the pancreas and has been designated as a marker of islet precursor cells [8] . NGN3 is first detected at embryonic day 9. Its levels peak at embryonic day 15.5, then decline to the point where little or no NGN3 is detected in the early postnatal pancreas [5, 9] . These findings do not preclude the re-emergence of NGN3 in more mature islets, and there are a few reports of Ngn3 expression in adult islets [31, 32] . We observed both Ngn3 mRNA and NGN3 protein in adult (3-to 6-month-old) mouse islets and human islets (49-65 years old), as well as in MIN6 cells. These findings support the possibility that NGN3 may play a role in the adult endocrine pancreas, perhaps in the regulation of cell fate. Whether NGN3-positive adult islet cells represent cells with 'precursor potential' remains to be addressed. While the RT-PCR and western blot data leave little doubt that NGN3 can be detected in adult islets, its identification in multiple cellular compartments using immunofluorescence microscopy is intriguing. Although substantial NGN3 immunoreactivity could be found within the nucleus, cytoplasmic staining was more intense. While NGN3 is typically found in the nucleus during development, cytoplasmic NGN3 staining has been observed by others in postnatal islet cells, and it was suggested that this may represent a transitional state [33] . Interestingly, although overproduction of NGN3 protein using a TAT protein transduction domain was effective in the control of downstream target genes, it primarily resided in the cytoplasm [34] . Together, with these other findings, our data suggest the possibility that NGN3 may reside in both the cytoplasm and nucleus, depending on whether cells are developing or mature. This idea is consistent with the observation that many transcription factors critical for adult pancreatic beta cell function (e.g. forkhead box O1 [Foxo1], cAMP response element binding [CREB] protein and pancreatic and duodenal homeobox 1 [Pdx1]) are known to traffic to and from the nucleus [35] [36] [37] . In our mature islet cells, therefore, it is possible that NGN3 could be further activated and that additional factors other than Notch may be required for its full action.
Our results support an important role for Notch signalling in cell-fate decisions in mature islet cells. Interestingly, the alterations in Notch have been associated with different human cancers including pancreatic cancer [11, 27, 38] , suggesting malfunction of this pathway can have significant consequences in the pancreas. To uncover the function of Notch in adult islets we used DAPT, a gamma-secretase inhibitor, as well as Psen1 overexpression to increase gamma-secretase activity. DAPT is known to suppress Notch activation in many cell types [24] [25] [26] [27] and we confirmed this in mature islets. DAPT induced caspase 3-dependent apoptosis in human and mouse islets, and MIN6 cells. Notably, DAPT evoked apoptosis in lowglucose, but not high-glucose conditions. This susceptibility to programmed cell death in the presence of low glucose is reminiscent of the situation in islets with reduced expression of the MODY gene Pdx1 [22] , or increased levels of the type 2 diabetes susceptibility gene calpain 10 (Capn10) [17] . Further studies are required to characterise additional downstream mechanisms of DAPT-induced beta cell apoptosis.
It should be noted that while modulating Notch activation via the gamma-secretase is quite effective in our studies, it remains possible that additional targets of the gammasecretase and/or gamma-secretase-independent targets of PSEN1 may have also been involved. Testing the specific role of Notch in beta cell function and survival will probably involve the simultaneous knockdown or knockout of all Notch isoforms in adult islet cells. Nevertheless, our results point to the importance of active Notch signalling in preventing apoptosis of beta cells in adult islets, specifically in low-glucose conditions. We also implicated growth factor signalling pathways in the control of Notch activity in adult islets, but we were unable to directly observe effects of specific growth factors under the conditions tested. Whether this reflects the requirement for multiple stimuli or other experimental parameters is not known. In the present study, we also examined islet function and found that gammasecretase-dependent Notch cleavage is not involved in the maintenance of differentiated function of mature islets, assessed by glucose-stimulated insulin secretion (at least in the time-frame studied). This finding illustrates the possibility that programmed cell death can be in process in some islet cells, while total islet secretory function remains intact. Again, this is reminiscent of the situation in mice lacking one allele of Pdx1 [22] .
It is well established that beta cell apoptosis is a critical event in the pathogenesis of diabetes and that beta cell death limits the potential of clinical islet transplantation [39] [40] [41] [42] . In type 1 diabetes, a greater number of beta cells remain than previously appreciated and preventing ongoing 
